FDA Inspection 1121341 - Seattle Reproductive Medicine, Inc., P.S. - February 28, 2020

Record Details

This FDA Inspection record concerns Seattle Reproductive Medicine, Inc., P.S., with an inspection on February 28, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Seattle Reproductive Medicine, Inc., P.S.
Inspection Date: February 28, 2020
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 633b5f0b-0061-4893-be7a-5b58aa767d3f